Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

NCT00055575 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 2
Overall status
Terminated
Start date
February 27, 2003
Completion date
February 2, 2015
Enrollment
197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, healthy, mood disorders, unipolar depression